In addition, treatment of recombinant IFN-β (rIFN-β) enhanced the bacterial clearance from 6.34 log CFU/ml to 5.66 log CFU/ml in WT BMDMs, but not in IFNAR-deficient cells (Figures 1H, I) at 72 h after infection. This evidence concerns the gene IFNB1 and infection.